Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
LUNG CANCER
May 15, 2024
Exploring the Use of Neoadjuvant Chemoimmunotherapy in NSCLC
May 15, 2024
Results of Postmarketing Safety Assessment for Lurbinectedin
May 15, 2024
Disparities in Screening, Treatment of Lung Cancer
April 18, 2024
PD-1 Inhibitors Associated With Greater Pneumonitis Risk
April 18, 2024
Risk Factors for Lung Cancer in Nonsmokers
April 18, 2024
Lurbinectedin Superior to Topotecan for Treating SCLC
July 18, 2023
A Look at NSCLC and Its Current and Emerging Therapies
June 27, 2023
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
April 4, 2023
Postmenopausal Hormone Therapy Lowers Risk of Lung Cancer
April 4, 2023
Depression in NSCLC Patients Correlated With Elevated Inflammation
April 4, 2023
Impact of Immune Checkpoint Inhibitors on SCLC Chemotherapy
March 3, 2023
Targeted Therapies Underused in Medicaid Programs
March 3, 2023
Cost Effectiveness of Risk-Based Lung Cancer Screening
Load More
X
May 2024
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image